FDA
approval
· 2018-05-21
FDA Approved: DOPTELET — Original Application (AkaRx, Inc.)
Summary
FDA approved DOPTELET (avatrombopag) from AkaRx, Inc. for reducing the need for platelet transfusions in adults with chronic liver disease undergoing an electiv…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DOPTELET (AVATROMBOPAG MALEATE)